Matinas BioPharma Holdings Inc (MTNB)
0.1749
-0.01
(-4.58%)
USD |
NYAM |
May 03, 16:00
0.1749
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Price to Book Value: 1.976 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.976 |
| May 02, 2024 | 2.071 |
| May 01, 2024 | 2.063 |
| April 30, 2024 | 2.098 |
| April 29, 2024 | 2.074 |
| April 26, 2024 | 2.022 |
| April 25, 2024 | 2.051 |
| April 24, 2024 | 2.054 |
| April 23, 2024 | 2.051 |
| April 22, 2024 | 2.034 |
| April 19, 2024 | 2.121 |
| April 18, 2024 | 2.147 |
| April 17, 2024 | 2.170 |
| April 16, 2024 | 2.259 |
| April 15, 2024 | 2.288 |
| April 12, 2024 | 2.296 |
| April 11, 2024 | 2.279 |
| April 10, 2024 | 2.362 |
| April 09, 2024 | 2.406 |
| April 08, 2024 | 2.362 |
| April 05, 2024 | 2.405 |
| April 04, 2024 | 2.479 |
| April 03, 2024 | 2.571 |
| April 02, 2024 | 3.955 |
| April 01, 2024 | 4.179 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.062 |
| March 27, 2024 | 3.276 |
| March 26, 2024 | 3.228 |
| March 25, 2024 | 3.279 |
| March 22, 2024 | 3.141 |
| March 21, 2024 | 3.008 |
| March 20, 2024 | 3.254 |
| March 19, 2024 | 3.207 |
| March 18, 2024 | 3.079 |
| March 15, 2024 | 3.387 |
| March 14, 2024 | 2.688 |
| March 13, 2024 | 2.879 |
| March 12, 2024 | 2.935 |
| March 11, 2024 | 3.059 |
| March 08, 2024 | 3.048 |
| March 07, 2024 | 2.924 |
| March 06, 2024 | 2.934 |
| March 05, 2024 | 2.978 |
| March 04, 2024 | 3.038 |
| March 01, 2024 | 3.288 |
| February 29, 2024 | 3.162 |
| February 28, 2024 | 3.082 |
| February 27, 2024 | 3.021 |
| February 26, 2024 | 3.037 |
| February 23, 2024 | 2.702 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.975
Minimum
Sep 25 2023
12.97
Maximum
Jan 02 2020
3.439
Average
3.162
Median
Feb 29 2024
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.187 |
| Oragenics Inc | 3.043 |
Price to Book Value Related Metrics
| PS Ratio | 8.868 |
| Price | 0.1749 |
| Earnings Yield | -68.61% |
| Market Cap | 38.04M |